What is Myriad Genetics's price / sales?

Myriad Genetics (MYGN) reported price / sales of 0.5× in Q1 2026.

How has Myriad Genetics's price / sales changed year-over-year?

Myriad Genetics's price / sales decreased by 47.9% year-over-year, from 1× to 0.5×.

What is the long-term trend for Myriad Genetics's price / sales?

Over 5 years (2020 to 2025), Myriad Genetics's price / sales has grown at a -22.4% compound annual growth rate (CAGR), from 2.5× to 0.7×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Myriad Genetics MYGN Price / sales

Price / sales at other companies

Labcorp HoldingsLH

1.6×+0.1×

Quest DiagnosticsDGX

1.9×+0.1×

NeoGenomicsNEO

1.3×-0.5×

VeracyteVCYT

4.7×-0.3×

Guardant HealthGH

11.2×+4.4×

Natera, Inc.NTRA

11.3×+0.9×

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

market cap/total revenue=0.5×

Based on the most recent quarter.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's price / sales?: Myriad Genetics (MYGN) reported price / sales of 0.5× in Q1 2026.
How has Myriad Genetics's price / sales changed year-over-year?: Myriad Genetics's price / sales decreased by 47.9% year-over-year, from 1× to 0.5×.
What is the long-term trend for Myriad Genetics's price / sales?: Over 5 years (2020 to 2025), Myriad Genetics's price / sales has grown at a -22.4% compound annual growth rate (CAGR), from 2.5× to 0.7×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.